Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide licensed for weight loss in the UK comes ready to use — no mixing, no measuring, no reconstitution required. If you have searched for how to mix semaglutide, the most helpful thing to say first is this: Wegovy, the licensed semaglutide injection for weight management, is a pre-filled pen that delivers a precise, pre-measured dose every time. There is nothing to mix. The question itself is worth unpacking, because it often points to something important about where the medicine has come from — and whether it is the right product at all. Semaglutide is a prescription-only medicine; a prescriber assesses your suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide for weight management is licensed in the UK under the brand name Wegovy. The pen arrives pre-filled; you click, inject, and that is the complete process. No vials. No syringes drawn up by hand. No diluent added. So when the phrase "how to mix semaglutide" circulates online, it is almost always describing something different: compounded or powdered semaglutide, typically sold as a vial of lyophilised (freeze-dried) peptide alongside a separate bacteriostatic water solution, which the patient mixes themselves before injecting.
These compounded products are not approved by the MHRA. They do not carry the same manufacturing standards as licensed medicines. Concentration errors are common (the maths involved in reconstituting a powder to a target dose is genuinely easy to get wrong) and contamination during home preparation introduces risks that simply do not exist with a factory-sealed, single-use pen. The MHRA has warned publicly about unlicensed weight-loss products circulating online, and reports of suspect products can be submitted directly via the Yellow Card scheme.
If you have already been prescribed Wegovy through a registered UK prescriber and are holding a genuine pen, the full guide to Wegovy on our site covers the injection process step by step, including site rotation, storage, and what to expect from each dose.
For anyone who has already obtained a powdered product and wants to understand the process: the preparation typically involves adding a precise volume of bacteriostatic water to a vial of lyophilised peptide, then drawing up a calculated volume into an insulin syringe for each dose. The target is a specific concentration of micrograms per millilitre. Even a small error (in the volume of water used, or in the volume drawn) can produce a dose that is significantly higher or lower than intended.
A higher-than-intended dose increases the risk of severe nausea, vomiting and dehydration, as well as more serious effects on the pancreas and gallbladder. A lower dose means you are not receiving the medicine you think you are. Neither outcome is safe. This is not a theoretical concern; it is one reason why licensed, pre-filled delivery systems exist.
Our explainer on how semaglutide works covers the pharmacology without venturing into preparation instructions, that distinction matters, because a clinician's job is to oversee dosing, not to hand it to the patient unsupported. If you want to understand what genuinely should not be combined with semaglutide, that page addresses real interactions and timing considerations worth knowing.
The NHS describes semaglutide as a once-weekly injection administered using the pre-filled pen) the NHS medicines page for semaglutide is a reliable starting point for understanding how the medicine works and what to expect. That page does not describe reconstitution, because there is none in the licensed product.
A practical check anyone can do in under a minute: look up the pharmacy supplying you on the GPhC pharmacy register. Enter the pharmacy's name or registration number and confirm it appears as a registered premises. If it does not, that is a significant warning sign about anything they are supplying.
For those who are exploring weight-loss treatment options and want to understand the cost picture alongside the clinical one, there is a broader breakdown of what to expect from private treatment. The short version: a legitimate supply of Wegovy in the UK comes through a prescription, from a GPhC-registered pharmacy, with no home preparation involved. Prices vary by dose and provider, the Wegovy access page covers what the process looks like in practice.
If you have questions about your specific situation or have been using a compounded product and want to transition to a licensed medicine, speaking to our prescribers is the right place to start. A clinician reviews every consultation the same day (a real person, not an automated system) and can discuss your history, your current dose, and the safest way forward. If you have been given a powdered product and need to understand the practicalities, our guides on self mix semaglutide and on how to mix semaglutide 2mg set out what the process involves, so you can make an informed decision about whether to continue or switch to a licensed alternative.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.